<?xml version="1.0" encoding="UTF-8"?>
<ref id="B292-pharmaceuticals-12-00147">
 <label>292.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Pearce</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mason</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Tumpey</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Wentworth</surname>
    <given-names>D.E.</given-names>
   </name>
  </person-group>
  <article-title>Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus</article-title>
  <source>PLoS ONE</source>
  <year>2013</year>
  <volume>8</volume>
  <elocation-id>e67616</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0067616</pub-id>
  <?supplied-pmid 23799150?>
  <pub-id pub-id-type="pmid">23799150</pub-id>
 </element-citation>
</ref>
